Is Galectin Therapeutics Inc. (GALT) a Buy, Sell, or Hold?
Galectin Therapeutics Inc.
NASDAQ:GALT
$4.76 USD
-$0.58 (-10.86%)
- Volume
- 528.8K
- Average Volume
- 609.99K
- Market Capitalization
- $313.48M
- P/E Ratio
- -11.70
- Dividend Yield
- 0.00%
- Price Target
- $11.00
- Year High
- $7.13
- Year Low
- $2.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.15
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
75
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
110
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 2.01M
GALT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
GALT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Shlevin Harold H. | director | 2026-06-26 | M-Exempt | 1.23 | 2026-06-30 |
| Shlevin Harold H. | director | 2026-06-29 | M-Exempt | 1.23 | 2026-06-30 |
| Shlevin Harold H. | director | 2026-06-29 | M-Exempt | 1.23 | 2026-06-30 |
| Shlevin Harold H. | director | 2026-06-26 | M-Exempt | 1.23 | 2026-06-30 |
| Shlevin Harold H. | director | 2026-06-29 | S-Sale | 5.04 | 2026-06-30 |
| Shlevin Harold H. | director | 2026-06-26 | S-Sale | 5 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-26 | M-Exempt | 2.2 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-29 | M-Exempt | 2.5 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-26 | M-Exempt | 2.5 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-26 | M-Exempt | 2.5 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-26 | M-Exempt | 2.2 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-29 | M-Exempt | 2.5 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-26 | S-Sale | 5 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-29 | S-Sale | 5.04 | 2026-06-30 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-23 | M-Exempt | 1.23 | 2026-06-25 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-23 | M-Exempt | 1.23 | 2026-06-25 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-06-23 | S-Sale | 3.14 | 2026-06-25 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-05-26 | M-Exempt | 1.23 | 2026-05-28 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-05-26 | M-Exempt | 1.23 | 2026-05-28 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-05-26 | S-Sale | 3.1004 | 2026-05-28 |
| Brem Henry | director | 2026-03-12 | A-Award | 3.16 | 2026-03-17 |
| Brem Henry | director | 2026-03-12 | 0 | 2026-03-17 | |
| ELDRED KARY | director | 2026-02-06 | P-Purchase | 2.7 | 2026-02-09 |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-16 | A-Award | 3.04 | 2026-01-22 |
| CARSON BENJAMIN SR | director | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| Zordani Richard A. Jr. | director | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-01-16 | A-Award | 0 | 2026-01-21 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| FREEMAN KEVIN D | director | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| ELDRED KARY | director | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-16 | A-Award | 0 | 2026-01-21 |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| CALLICUTT JACK W | officer: Chief Financial Officer | 2026-01-16 | A-Award | 0 | 2026-01-21 |
| CALLICUTT JACK W | officer: Chief Financial Officer | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| Shlevin Harold H. | director | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| OMENN GILBERT S | director | 2026-01-16 | A-Award | 0 | 2026-01-21 |
| AMELIO GILBERT F | director | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| Schwartz Elissa J. | director | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| Uihlein Richard E | director, 10 percent owner: | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| Uihlein Richard E | director, 10 percent owner: | 2026-01-16 | A-Award | 3.04 | 2026-01-21 |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-05 | 3.88 | 2026-01-13 | |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-02 | M-Exempt | 0 | 2026-01-06 |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-02 | S-Sale | 4.1968 | 2026-01-06 |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-05 | S-Sale | 3.9069 | 2026-01-06 |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-06 | S-Sale | 3.5772 | 2026-01-06 |
| LEWIS JOEL | director, officer: President and CEO | 2026-01-02 | M-Exempt | 0 | 2026-01-06 |
| CALLICUTT JACK W | officer: Chief Financial Officer | 2026-01-02 | M-Exempt | 0 | 2026-01-06 |
| CALLICUTT JACK W | officer: Chief Financial Officer | 2026-01-02 | S-Sale | 4.1968 | 2026-01-06 |
| CALLICUTT JACK W | officer: Chief Financial Officer | 2026-01-05 | S-Sale | 3.8978 | 2026-01-06 |
| CALLICUTT JACK W | officer: Chief Financial Officer | 2026-01-06 | S-Sale | 3.6698 | 2026-01-06 |
| CALLICUTT JACK W | officer: Chief Financial Officer | 2026-01-01 | M-Exempt | 0 | 2026-01-06 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-01-02 | M-Exempt | 0 | 2026-01-06 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-01-02 | S-Sale | 4.1968 | 2026-01-06 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-01-05 | S-Sale | 3.8985 | 2026-01-06 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-01-01 | M-Exempt | 0 | 2026-01-06 |
| Jamil Khurram | officer: Chief Medical Officer | 2026-01-06 | S-Sale | 3.6466 | 2026-01-06 |
| Jamil Khurram | officer: Chief Medical Officer | 2025-12-31 | M-Exempt | 1.23 | 2026-01-05 |
| Jamil Khurram | officer: Chief Medical Officer | 2025-12-31 | M-Exempt | 1.23 | 2026-01-05 |
| Jamil Khurram | officer: Chief Medical Officer | 2025-12-31 | S-Sale | 4.0725 | 2026-01-05 |
| FREEMAN KEVIN D | director | 2025-12-23 | P-Purchase | 3.548 | 2025-12-23 |
| ELDRED KARY | director | 2025-12-23 | P-Purchase | 3.73 | 2025-12-23 |
| LEWIS JOEL | director, officer: President and CEO | 2025-12-17 | M-Exempt | 2.86 | 2025-12-19 |
| LEWIS JOEL | director, officer: President and CEO | 2025-12-17 | S-Sale | 7.056 | 2025-12-19 |
| LEWIS JOEL | director, officer: President and CEO | 2025-12-17 | M-Exempt | 2.86 | 2025-12-19 |
| Jamil Khurram | officer: Chief Medical Officer | 2025-12-17 | M-Exempt | 2.2 | 2025-12-19 |
| Jamil Khurram | officer: Chief Medical Officer | 2025-12-17 | M-Exempt | 2.5 | 2025-12-19 |
| Jamil Khurram | officer: Chief Medical Officer | 2025-12-17 | M-Exempt | 2.5 | 2025-12-19 |
| Jamil Khurram | officer: Chief Medical Officer | 2025-12-17 | M-Exempt | 2.2 | 2025-12-19 |
| Jamil Khurram | officer: Chief Medical Officer | 2025-12-17 | S-Sale | 7.04 | 2025-12-19 |
| Shlevin Harold H. | director | 2025-12-17 | M-Exempt | 1.98 | 2025-12-19 |
| Shlevin Harold H. | director | 2025-12-17 | S-Sale | 7.038 | 2025-12-19 |
| Shlevin Harold H. | director | 2025-12-17 | S-Sale | 7.038 | 2025-12-19 |
| Shlevin Harold H. | director | 2025-12-17 | M-Exempt | 1.98 | 2025-12-19 |
| 10X Fund, L.P. | 10 percent owner | 2025-11-24 | J-Other | 0 | 2025-12-18 |
| 10X Fund, L.P. | 10 percent owner | 2025-12-16 | S-Sale | 6.66 | 2025-12-18 |
| Shlevin Harold H. | director | 2025-12-12 | M-Exempt | 4.16 | 2025-12-16 |
| Shlevin Harold H. | director | 2025-12-12 | M-Exempt | 4.16 | 2025-12-16 |
| Shlevin Harold H. | director | 2025-12-15 | M-Exempt | 4.16 | 2025-12-16 |
| Shlevin Harold H. | director | 2025-12-12 | S-Sale | 6.274 | 2025-12-16 |
| Shlevin Harold H. | director | 2025-12-15 | S-Sale | 6.3 | 2025-12-16 |
| Shlevin Harold H. | director | 2025-12-15 | M-Exempt | 4.16 | 2025-12-16 |
| Shlevin Harold H. | director | 2025-12-09 | M-Exempt | 4.16 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 2.86 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 2.11 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 1.72 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 2.11 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 2.86 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 1.98 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 2.11 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 1.11 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-09 | M-Exempt | 4.16 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 1.72 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 2.11 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 1.98 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | M-Exempt | 1.11 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | S-Sale | 5.962 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | S-Sale | 5.962 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | S-Sale | 5.946 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-08 | S-Sale | 6.019 | 2025-12-10 |
| Shlevin Harold H. | director | 2025-12-09 | S-Sale | 6.266 | 2025-12-10 |